US Patent Issued to ORYZON GENOMICS on March 3 for "Combinations of LSD1 inhibitors for use in the treatment of solid tumors" (Spanish, American Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,559, issued on March 3, was assigned to ORYZON GENOMICS S.A. (Madrid).

"Combinations of LSD1 inhibitors for use in the treatment of solid tumors" was invented by Mark D. Demario (New York), Tamara Maes (Cornella de Llobregat, Spain), William E. Pierceall (New York), Fiona Mack (New York) and Serena Lunardi (Cornella de Llobregat, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The instant invention relates to therapeutic combinations of LSD1 inhibitors and one or more other active pharmaceutical ingredient(s) or pharmaceutically acceptable salts thereof. The combinations are particularly useful for treating neoplastic diseases, such as cancer, ...